Filter posts

The Challenges and Risks of Adopting Foreign Price Controls

The Trump Administration is moving forward with a plan to import foreign price controls into …

BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN

BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest …

Why Are Patients Facing Higher Costs When They Go to the Pharmacy?

BIO is out with a new whiteboard video that explores why more and more patients …

“Health Care’s Big Spending Mismatch”

This week, Axios reported on new data that shows “the health care services that rack …

A Few Questions as PBMs Have Their Day on Capitol Hill

Tomorrow, the Senate Finance Committee will examine the role of pharmacy benefit managers (PBMs) in …

Dr. Emanuel Misses the Mark with Latest Industry Attack

Writing for The Atlantic, Dr. Ezekiel Emanuel accuses the biopharmaceutical industry of being “deceptive” when …

Hits to Patients Keep on Coming

At a time when prescription drug prices and spending are remarkably stable, patients are getting …

Report: Patients More Likely to Skip Therapy as Out-of-Pocket Costs Rise

IQVIA — a nonpartisan health care research firm — is out with troubling new data …

On the President’s Drug Cost Plan, Three Important Concerns

Part 1. Restricting access under Medicare Part D  The Trump administration is out with its …